Schizophrenia Clinical Trials

Showing 201-220 of 1,356 trials

RECRUITINGPhase 1

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

NCT06105151

This study will consist of 2 parts: Part Ⅰ - Single Ascending Dose (SAD) study, Part Ⅱ - Food Effect (FE) study

Schizophrenia

Vigonvita Life Sciences82 participantsStarted Oct 2023

Beijing, Beijing Municipality, China

Active Not RecruitingEARLY Phase 1

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

NCT02102113

The overall purpose of this study is to determine whether a family history of psychosis is associated with an altered cannabinoid system. This will be tested by studying individuals with and without a family history of psychosis and comparing their responses to delta 9-tetrahydrocannabinol (THC), a probe of the cannabinoid system. We hypothesize, that compared to controls with no family history of psychoses, individuals with a family history of psychoses will have an altered response to THC.

PsychosisCannabis UseTHC+2 more

Yale University21 participantsStarted Jan 2014

West Haven, Connecticut, United States

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

Related Searches

The Effects of tDCS on Illness Awareness in Schizophrenia

App and Body Fat Scale in the Management of Overweight Patients

Cultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in Pakistan

Restoring Spindle and Thalamocortical Efficiency in Early-Course Schizophrenia Patients Using Auditory Stimulation

Efficacy of Hi-tACS for Schizophrenia Negative Symptoms

Baduanjin on Patients With Schizophrenia

Focused Ultrasound Modulation of the Globus Pallidus Interna in Schizophrenia

Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination

Metabolic Effects of Adjunctive Lumateperone Treatment in Clozapine-Treated Patients With Schizophrenia

HYEEG Discourse in Psychosis: A Neurobehavioural Study

Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic Profiling

7-week Study With CT-155 in People With Schizophrenia

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections

ACT-Based Psychoeducation for Schizophrenia Caregivers

The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

Online HD-tDCS Over the Left DLPFC During a Working Memory Task for Treating Negative Symptoms of Schizophrenia

Effects of Psyllium on Constipation in Schizo-phrenic: A Randomized Controlled Crossover Trial